AlphAIAlphAI — Financial news for AI agents
marketscreener.comSEP 251 min read$SNPS

HSBC Upgrades Synopsys to Buy From Hold, Lifts Price Target to $700 From $490

HSBC upgraded Synopsys (SNPS) from Hold to Buy and raised its price target from $490 to $700. The company's shares have risen 2.87% in the past 5 days and 11.48% year-to-date.

Original reporting
marketscreener.com
Published Sep 25, 2026, 11:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 11:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$SNPS
Bullish
high confidence
Mentioned
$SNPS
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$SNPSBullishHigh
01

Why it matters

The upgrade may attract new buying interest and support price appreciation.

02

Market read

Analyst upgrades are a common catalyst for short-term price moves in tech stocks.

03

What to watch

Potential competitive pressure from emerging AI design tools.

Relevance 7/10Novelty 7/10Timing: pre-market

Background

HSBC's research team revised its valuation and visibility outlook for Synopsys.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

HSBC upgraded Synopsys to Buy and raised its price target to $700 from $490.

Expected impact

Potential short-term price increase as investors adjust positions.

Evidence & confidence

Upgrade and higher target provide a clear catalyst for immediate trade action.

Market effects

Sector

May lift sentiment in the EDA/software sector.

Regional

Primarily affects US tech equities.

Global

Limited to investors tracking semiconductor design tools.

Counterpoint

What could challenge this read

Upgrade could be premature if earnings miss expectations.

Key entities

  • company
    Synopsys

    Electronic design automation software provider.

  • analyst
    HSBC

    Investment bank issuing the upgrade.

Read at source← All news

Related articles

SEP 24
$SNPSMed

SNPS Looks 37.0% Undervalued on GF Value™

BNP Paribas upgraded Synopsys (SNPS) to Neutral with a $420 price target, citing improved fundamentals. GF Value™ estimates SNPS is 37.0% undervalued at $414.43 vs. $657.46 intrinsic value. SNPS has a GF Score™ of 90/100, strong growth, and profitability but moderate financial strength. Insider selling totaled $48.2M over 12 months. Upcoming investor day on September 30 may provide further clarity.

gurufocus.com3 min
SEP 18
$SNPSMedAI 8/10

Why Has Synopsys Stopped Leading With Bad News?

Synopsys (SNPS) shifted its earnings call focus from past issues, like China's export restrictions and IP business underperformance, to new growth areas like Multiphysics Fusion with Ansys and agentic AI. Design Automation grew to $7.7-7.9B, while Design IP remained at $1.8B. Management expects new initiatives to boost EDA growth in 2027, but Design IP's turnaround is based on a single quarter of growth.

finance.yahoo.com2 min
SEP 8
$SNPSMed

SNPS Upgraded by Morgan Stanley -- Price Target Maintained at $5

Morgan Stanley upgraded Synopsys (SNPS) to Overweight, maintaining a $500 price target. The stock is trading at $396.11, which is 39.9% undervalued according to its GF Value™ of $659.20. Synopsys has a GF Score™ of 88/100, indicating strong growth potential but concerns about valuation. Insider activity shows significant selling, with $40.7 million in sales over the last three months.

gurufocus.com2 min